J. Klastersky

A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies

Michel Moreau, J. Klastersky, Alexandre Vargas Schwarzbold et al. · Annals of Oncology · 2009 · 82 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +8

Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis

Yassine Lalami, M. Paesmans, F. Muanza et al. · Annals of Oncology · 2005 · 50 citations · Full text

Disease Progression, Regimen-specific Risk Factors, Medicine +8

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

J. Klastersky, P. Mommen, F. Cantraine et al. · European Journal of Cancer and Clinical Oncology · 1986 · 46 citations

Pneumococcal Immunization, Immunology, Respiratory Infection +5

Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer

Wilfried Schroyens, Elias Tueni, P. Dodion et al. · European Journal of Cancer and Clinical Oncology · 1990 · 30 citations

Neck Cancer, Oncology, Clinical Predictive Value +12

A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy

Jean‐Paul Sculier, Thierry Berghmans, J.J. Lafitte et al. · Lung Cancer · 2002 · 29 citations

Oncology, Cancer Management, Pharmacology +8